Podcast

ANA Investigates Cannabis and Cannabinoids for MS Symptoms

07/20/2020

In this podcast, Michelle Cameron, MD, PT, talks about the federal and state legalities surrounding cannabinoid use, how cannabinoids go through the FDA approval process, and how cannabinoids can be used to treat symptoms of multiple sclerosis.

Michelle Cameron

Michelle Cameron, MD, PT, MCR, is associate professor of neurology at the  Oregon Health & Science University in Portland, Oregon.

 

Published in partnership with American Neurological Association

For more ANA investigates podcasts, visit our partners at the American Neurological Association.

Related Content

Hepatology
Hepatology
Stephen Harrison, MD, on the Prevalence of NAFLD in the United States
09/12/2019
Dr Harrison discusses the prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis in the United States, the correlation between NAFLD and obesity, and more.
09/12/2019
Stress and Burnout
Stress and Burnout
Sarah Piraino, PharmD, on Diabetes and COVID-19
10/27/2011
In this podcast, Sarah Piraino, PharmD, speaks about glycemic outcomes in people with diabetes in the presence or absence of COVID-19 infection, including gaps that exist in the research and future...
10/27/2011
Osteoporosis
Osteoporosis
Sonali Thosani, MD, on Bone Health Among Long-Term Cancer Survivors
09/12/2019
Dr Thosani, from The University of Texas MD Anderson Cancer Center, discusses the management of bone health among long-term cancer survivors, the importance of osteoporosis screening, and more.
09/12/2019
Hormones
Hormones
Susan Davis, PhD, on the New Consensus Statement on Testosterone Use in Women
01/09/2022
International Menopause Society President Susan Davis, PhD, discusses key points from the latest consensus statement on the use of testosterone therapy in women. The statement has been endorsed by various...
01/09/2022
Cardiovascular Diseases
Cardiovascular Diseases
Emily B. Levitan, ScD, on High-Intensity Statin Use in the United States
11/27/2019
She talks about her research that examined the relative strength of associations between region, hospital, and patient characteristics with high-intensity statin use after myocardial...
11/27/2019